ScienceMed®

Clinical outcomes of periodontal regeneration using biologic agents alone or in combination with graft materials for intrabony defects: A systematic review and meta-analysis

Ortopedia
Imagem de arquivo, ilustrativa — não é do estudo. Feixes de músculo esquelético em cortes longitudinal e transversal, ao microscópio óptico. Berkshire Community College Bioscience Image Library · CC0 · Wikimedia Commons

MetanáliseNível 1 · Evidência consolidadaJournal of dentistry31 ago 20255 citações

Salvar

Resumo original em inglês

O que aconteceu

This systematic review with meta-analysis investigated whether combining bone grafts with biologic agents enhances clinical outcomes compared to biologic agents alone in the regenerative treatment of periodontal intrabony defects.

Electronic searches were conducted in PubMed, Web of Science, and Scopus up to December 18, 2024, following PRISMA guidelines. Manual screening of major periodontal journals complemented the search.

Randomized controlled trials with ≥6 months follow-up were included if they compared biologic agents alone (e.g., enamel matrix derivative, platelet-rich fibrin, recombinant growth factors) to their combination with bone grafts in the treatment of intrabony defects. Primary outcomes were probing pocket depth (PPD) reduction, clinical attachment level (CAL) gain, and radiographic bone level (RBL) gain.

O que encontraram

Twenty-one RCTs (739 patients, 828 defects) met inclusion criteria. Combination therapy resulted in significantly greater PPD reduction (mean difference: 0.38 mm; p = 0.02) and RBL gain (0.81 mm; p = 0.003). CAL gain showed a favorable but non-significant trend (0.30 mm; p = 0.22). Gingival recession was slightly lower in the graft group, while BoP and PI were unaffected. Subgroup analyses suggested that PRF and growth factors derive more benefit from grafting, whereas enamel matrix derivatives (EMD) offered comparable outcomes with or without grafts.

Por que isso importa

Limited yet measurable improvements in regenerative outcomes are obtained with the addition of graft materials to PRF and growth factors, while EMD seems to yield comparable outcomes regardless of grafting.

These findings suggest that while grafting can enhance certain clinical parameters, its added value may depend on the specific biologic agent used, supporting a selective rather than systematic use in periodontal regenerative procedures.

Resumo publicado sob licença CC BY. A tradução para o português ainda não chegou a este estudo.

O estudo original

Clinical outcomes of periodontal regeneration using biologic agents alone or in combination with graft materials for intrabony defects: A systematic review and meta-analysis

Nicola Alberto Valente, Claudia Pileri, Lorenzo Floris, Nicola Carrus, Zuhair S Natto, Marco Clementini

Descritores MeSH

  • Alveolar Bone Loss
  • Guided Tissue Regeneration, Periodontal
  • Bone Transplantation
  • Biological Products
  • Humans
  • Randomized Controlled Trials as Topic
  • Treatment Outcome
  • Platelet-Rich Fibrin
  • Intercellular Signaling Peptides and Proteins
  • Bone Regeneration

Veja também